Fig. 7From: Pharmacokinetics and biodistribution of a novel anticancer thyrointegrin αvβ3 antagonist: triazole modified tetraiodothyroacetic acid conjugated to polyethylene glycol (P-bi-TAT)Time course of plasma levels of P-bi-TAT (10 mg/kg) in rats n = 4. Error bars represent standard errors of the meanBack to article page